PriceTargets.com logo

Clarivate - CLVT Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $3.02
  • Forecasted Upside: 50.46%
  • Number of Analysts: 8
  • Breakdown:
  • 3 Sell Ratings
  • 4 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.01 As of 07/31/2026 04:59 PM ET
▼ -0.005 (-0.25%)

This chart shows the closing price for CLVT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Clarivate Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLVT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLVT

Analyst Price Target is $3.02
▲ +50.46% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Clarivate in the last 3 months. The average price target is $3.02, with a high forecast of $5.00 and a low forecast of $2.00. The average price target represents a 50.46% upside from the last price of $2.01.

This chart shows the closing price for CLVT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 8 polled investment analysts is to reduce stock in Clarivate. This rating has held steady since May 2025, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
2/6/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
5/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
11/3/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
2/1/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings
Ratings as of
5/2/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings
Ratings as of
7/1/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
7/31/2026

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/30/2026BarclaysLower TargetUnderweight ➝ Underweight$2.50 ➝ $2.00
7/30/2026CitigroupLower TargetNeutral ➝ Neutral$2.80 ➝ $2.50
7/30/2026The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$2.90 ➝ $2.60
7/30/2026Stifel NicolausLower TargetBuy ➝ Buy$6.00 ➝ $5.00
7/7/2026BarclaysBoost TargetUnderweight ➝ Underweight$2.40 ➝ $2.50
6/24/2026Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
3/27/2026Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
3/4/2026CitigroupLower TargetNeutral ➝ Neutral$4.25 ➝ $2.80
2/25/2026BarclaysLower TargetUnderweight ➝ Underweight$4.00 ➝ $2.40
2/25/2026Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$5.00 ➝ $3.00
1/8/2026The Goldman Sachs GroupDowngradeBuy ➝ Neutral$4.20 ➝ $3.60
12/29/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/22/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/17/2025Morgan StanleyReiterated RatingEqual Weight ➝ Underweight$5.00 ➝ $3.00
12/15/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/1/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
11/17/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
11/5/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
10/30/2025The Goldman Sachs GroupSet Target$4.20
10/14/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/27/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
9/3/2025Wolfe ResearchInitiated CoveragePeer Perform
7/18/2025Jefferies Financial GroupInitiated CoverageBuy ➝ Hold$5.20 ➝ $4.50
2/20/2025Royal Bank Of CanadaReiterated RatingSector Perform ➝ Sector Perform$6.00 ➝ $6.00
11/7/2024Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$7.00 ➝ $6.00
11/7/2024BarclaysLower TargetUnderweight ➝ Underweight$5.00 ➝ $4.00
11/6/2024William BlairDowngradeOutperform ➝ Market Perform
8/7/2024BarclaysLower TargetUnderweight ➝ Underweight$6.00 ➝ $5.00
8/7/2024Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$8.00 ➝ $7.00
5/9/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$8.50 ➝ $7.50
2/28/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$9.00 ➝ $8.00
2/28/2024BarclaysLower TargetUnderweight ➝ Underweight$7.00 ➝ $6.00
2/28/2024Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$10.00 ➝ $8.00
2/28/2024OppenheimerLower TargetOutperform ➝ Outperform$11.00 ➝ $10.00
1/8/2024OppenheimerBoost TargetOutperform ➝ Outperform$10.00 ➝ $11.00
12/15/2023Wells Fargo & CompanyReiterated RatingEqual Weight ➝ Underweight$8.00
10/16/2023Jefferies Financial GroupUpgradeHold ➝ Buy$10.00 ➝ $8.50
10/5/2023OppenheimerLower TargetOutperform ➝ Outperform$11.00 ➝ $10.00
9/26/2023CitigroupLower TargetNeutral ➝ Neutral$10.00 ➝ $8.00
9/8/2023BarclaysDowngradeEqual Weight ➝ Underweight$8.00 ➝ $7.00
8/25/2023Royal Bank Of CanadaDowngradeOutperform ➝ Sector Perform$9.00 ➝ $8.00
8/7/2023Bank of AmericaDowngradeNeutral ➝ Underperform$10.00 ➝ $6.00
8/4/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$11.00 ➝ $9.00
8/4/2023BarclaysLower TargetEqual Weight ➝ Equal Weight$12.00 ➝ $8.00
8/4/2023Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$14.00 ➝ $9.00
8/4/2023The Goldman Sachs GroupLower TargetBuy ➝ Buy$11.00 ➝ $9.50
8/4/2023OppenheimerLower TargetOutperform ➝ Outperform$12.00 ➝ $11.00
8/4/2023Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$15.00 ➝ $8.00
6/12/2023OppenheimerInitiated CoverageOutperform$11.00
4/17/2023Royal Bank Of CanadaReiterated RatingOutperform$14.00
3/15/2023Bank of AmericaInitiated CoverageNeutral ➝ Neutral
3/10/2023Royal Bank Of CanadaReiterated RatingOutperform$14.00
3/2/2023Wells Fargo & CompanyBoost TargetOverweight$14.00 ➝ $15.00
3/2/2023Royal Bank Of CanadaBoost TargetOutperform$12.00 ➝ $14.00
2/6/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight$11.00 ➝ $12.00
1/4/2023Morgan StanleyLower TargetOverweight$13.00 ➝ $11.00
11/9/2022Wells Fargo & CompanyLower TargetOverweight$15.00 ➝ $14.00
11/9/2022The Goldman Sachs GroupLower TargetBuy$17.00 ➝ $14.50
11/9/2022Morgan StanleyLower TargetOverweight$14.00 ➝ $13.00
11/9/2022Royal Bank Of CanadaLower TargetOutperform$13.00 ➝ $12.00
10/7/2022Wells Fargo & CompanyLower TargetOverweight$18.00 ➝ $15.00
9/28/2022Royal Bank Of CanadaLower Target$16.00 ➝ $13.00
9/27/2022Morgan StanleyLower TargetOverweight$15.00 ➝ $14.00
9/13/2022Morgan StanleyLower TargetOverweight$16.00 ➝ $15.00
8/10/2022Morgan StanleyLower TargetOverweight$17.00 ➝ $16.00
7/12/2022Wells Fargo & CompanyInitiated CoverageOverweight$20.00
7/1/2022Royal Bank Of CanadaLower TargetOutperform$23.00 ➝ $18.00
5/26/2022Morgan StanleyLower TargetOverweight$18.00 ➝ $17.00
4/19/2022The Goldman Sachs GroupLower TargetBuy$23.00 ➝ $20.00
3/11/2022Morgan StanleyLower TargetOverweight$20.00 ➝ $19.00
2/7/2022Morgan StanleyLower TargetOverweight$28.00 ➝ $20.00
2/4/2022CitigroupDowngradeBuy ➝ Neutral$35.00 ➝ $16.00
2/3/2022BarclaysDowngradeOverweight ➝ Equal Weight$25.00 ➝ $16.00
1/18/2022BarclaysLower Target$30.00 ➝ $25.00
12/21/2021CitigroupInitiated CoverageBuy$35.00
12/13/2021The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$29.00
12/2/2021Morgan StanleyBoost TargetOverweight$27.00 ➝ $28.00
9/30/2021Morgan StanleyLower TargetOverweight$30.00 ➝ $28.00
8/16/2021Bank of AmericaInitiated CoverageBuy$28.00
(Data available from 8/1/2021 forward)

News Sentiment Rating

0.28 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2026
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2026
  • 6 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2026
  • 5 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2026
  • 0 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2026
  • 2 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2026
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2026
  • 11 very positive mentions
  • 24 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
8/1/2026

Current Sentiment

  • 11 very positive mentions
  • 24 positive mentions
  • 2 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Clarivate logo
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $2.01
Low: $1.90
High: $2.03

50 Day Range

MA: $2.27
Low: $1.91
High: $2.73

52 Week Range

Now: $2.01
Low: $1.66
High: $4.55

Volume

7,586,300 shs

Average Volume

7,041,357 shs

Market Capitalization

$1.28 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.38

Frequently Asked Questions

What sell-side analysts currently cover shares of Clarivate?

The following Wall Street sell-side analysts have issued reports on Clarivate in the last twelve months: Barclays PLC, Citigroup Inc., Morgan Stanley, Royal Bank Of Canada, Stifel Nicolaus, The Goldman Sachs Group, Inc., Wall Street Zen, Weiss Ratings, and Wolfe Research.
View the latest analyst ratings for CLVT.

What is the current price target for Clarivate?

0 Wall Street analysts have set twelve-month price targets for Clarivate in the last year. Their average twelve-month price target is $3.02, suggesting a possible upside of 50.5%. Stifel Nicolaus has the highest price target set, predicting CLVT will reach $5.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $2.00 for Clarivate in the next year.
View the latest price targets for CLVT.

What is the current consensus analyst rating for Clarivate?

Clarivate currently has 3 sell ratings, 4 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for CLVT.

What other companies compete with Clarivate?

Other companies that are similar to Clarivate include Sezzle, Figure Technology Solutions, Frontdoor, EquipmentShare.com and Andersen Group. Learn More about companies similar to Clarivate.

How do I contact Clarivate's investor relations team?

Clarivate's physical mailing address is 160 Blackfriars Road, London X0, SE1 8EZ. The company's listed phone number is 442074334000 and its investor relations email address is [email protected]. The official website for Clarivate is www.clarivate.com. Learn More about contacing Clarivate investor relations.